Bio-Rad Laboratories Total Long-Term Assets 2010-2024 | BIO
Bio-Rad Laboratories total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
- Bio-Rad Laboratories total long-term assets for the quarter ending September 30, 2024 were $6.632B, a 24.97% decline year-over-year.
- Bio-Rad Laboratories total long-term assets for 2023 were $9.251B, a 10.57% decline from 2022.
- Bio-Rad Laboratories total long-term assets for 2022 were $10.344B, a 34.57% decline from 2021.
- Bio-Rad Laboratories total long-term assets for 2021 were $15.809B, a 45.94% increase from 2020.
| Bio-Rad Laboratories Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2023 | $9,251 |
| 2022 | $10,344 |
| 2021 | $15,809 |
| 2020 | $10,833 |
| 2019 | $5,829 |
| 2018 | $3,588 |
| 2017 | $2,296 |
| 2016 | $2,006 |
| 2015 | $1,932 |
| 2014 | $1,625 |
| 2013 | $1,631 |
| 2012 | $1,507 |
| 2011 | $1,299 |
| 2010 | $1,087 |
| 2009 | $973 |
| Bio-Rad Laboratories Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $6,632 |
| 2024-03-31 | $9,549 |
| 2023-12-31 | $9,251 |
| 2023-09-30 | $8,749 |
| 2023-06-30 | $8,839 |
| 2023-03-31 | $10,390 |
| 2022-12-31 | $10,344 |
| 2022-09-30 | $8,918 |
| 2022-06-30 | $9,432 |
| 2022-03-31 | $11,070 |
| 2021-12-31 | $15,809 |
| 2021-09-30 | $17,487 |
| 2021-06-30 | $12,828 |
| 2021-03-31 | $11,758 |
| 2020-12-31 | $10,833 |
| 2020-09-30 | $9,697 |
| 2020-06-30 | $7,965 |
| 2020-03-31 | $6,602 |
| 2019-12-31 | $5,829 |
| 2019-09-30 | $5,129 |
| 2019-06-30 | $5,559 |
| 2019-03-31 | $4,831 |
| 2018-12-31 | $3,588 |
| 2018-09-30 | $4,684 |
| 2018-06-30 | $4,394 |
| 2018-03-31 | $4,238 |
| 2017-12-31 | $2,296 |
| 2017-09-30 | $2,293 |
| 2017-06-30 | $2,317 |
| 2017-03-31 | $2,220 |
| 2016-12-31 | $2,006 |
| 2016-09-30 | $2,170 |
| 2016-06-30 | $2,069 |
| 2016-03-31 | $1,978 |
| 2015-12-31 | $1,932 |
| 2015-09-30 | $1,872 |
| 2015-06-30 | $1,783 |
| 2015-03-31 | $1,624 |
| 2014-12-31 | $1,625 |
| 2014-09-30 | $1,622 |
| 2014-06-30 | $1,700 |
| 2014-03-31 | $1,675 |
| 2013-12-31 | $1,631 |
| 2013-09-30 | $1,606 |
| 2013-06-30 | $1,580 |
| 2013-03-31 | $1,592 |
| 2012-12-31 | $1,507 |
| 2012-09-30 | $1,458 |
| 2012-06-30 | $1,358 |
| 2012-03-31 | $1,370 |
| 2011-12-31 | $1,299 |
| 2011-09-30 | $1,092 |
| 2011-06-30 | $1,155 |
| 2011-03-31 | $1,111 |
| 2010-12-31 | $1,087 |
| 2010-09-30 | $1,030 |
| 2010-06-30 | $971 |
| 2010-03-31 | $1,004 |
| 2009-12-31 | $973 |
| 2009-09-30 | $975 |
| 2009-06-30 | $947 |
| 2009-03-31 | $905 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.338B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $202.220B | 25.79 |
| Stryker (SYK) | United States | $143.322B | 32.30 |
| Boston Scientific (BSX) | United States | $130.065B | 37.39 |
| Medtronic (MDT) | Ireland | $112.498B | 16.74 |
| EssilorLuxottica (ESLOY) | France | $111.686B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.423B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.501B | 28.26 |
| GE HealthCare Technologies (GEHC) | United States | $39.264B | 20.36 |
| ResMed (RMD) | United States | $37.048B | 30.44 |
| Terumo (TRUMY) | Japan | $29.575B | 41.77 |
| Koninklijke Philips (PHG) | Netherlands | $25.012B | 19.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.536B | 13.71 |
| Insulet (PODD) | United States | $18.791B | 74.86 |
| Baxter (BAX) | United States | $17.673B | 11.51 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.619B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.136B | 38.63 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.084B | 14.14 |
| Haemonetics (HAE) | United States | $4.474B | 21.43 |
| TG Therapeutics (TGTX) | United States | $4.460B | 0.00 |
| ICU Medical (ICUI) | United States | $4.318B | 41.21 |
| Prestige Consumer Healthcare (PBH) | United States | $3.983B | 19.75 |
| Perrigo (PRGO) | Ireland | $3.596B | 10.59 |
| Neogen (NEOG) | United States | $3.517B | 40.57 |
| Envista Holdings (NVST) | United States | $3.509B | 26.14 |
| Agios Pharmaceuticals (AGIO) | United States | $3.368B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $3.041B | 19.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.942B | 18.94 |
| LeMaitre Vascular (LMAT) | United States | $2.342B | 56.97 |
| Warby Parker (WRBY) | United States | $1.964B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.888B | 33.04 |
| AtriCure (ATRC) | United States | $1.826B | 0.00 |
| InMode (INMD) | Israel | $1.630B | 9.80 |
| Curaleaf Holdings (CURLF) | Canada | $1.384B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.357B | 9.70 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.280B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.206B | 0.00 |
| Owens & Minor (OMI) | United States | $0.995B | 7.77 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 17.04 |
| CeriBell (CBLL) | United States | $0.962B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.906B | 30.29 |
| Capricor Therapeutics (CAPR) | United States | $0.895B | 0.00 |
| Evolus (EOLS) | United States | $0.866B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.691B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.605B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.582B | 17.56 |
| Quanterix (QTRX) | United States | $0.580B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 0.00 |
| Valneva SE (VALN) | France | $0.426B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
| ZimVie (ZIMV) | United States | $0.393B | 33.12 |
| Viemed Healthcare (VMD) | United States | $0.353B | 33.59 |
| Cerus (CERS) | United States | $0.331B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.320B | 21.45 |
| Sanara MedTech (SMTI) | United States | $0.308B | 0.00 |
| Biote (BTMD) | United States | $0.301B | 13.90 |
| Zynex (ZYXI) | United States | $0.287B | 60.07 |
| Jin Medical (ZJYL) | China | $0.284B | 0.00 |
| MacroGenics (MGNX) | United States | $0.273B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.269B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 0.00 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.90 |
| High Tide (HITI) | Canada | $0.221B | 91.67 |
| Brainsway (BWAY) | Israel | $0.181B | 217.20 |
| Organigram Holdings (OGI) | Canada | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.151B | 20.39 |
| Rockwell Medical (RMTI) | United States | $0.137B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.116B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.111B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 9.82 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.10 |
| Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.079B | 2.67 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.20 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |